
Understanding Regulations in China, Japan and India for Device Expansion and Clinical Operations Excellence
Join us as we explore the advantages and intricacies to setting up a clinical study in China, India and Japan
Learn more about our China work.

Join us as we explore the advantages and intricacies to setting up a clinical study in China, India and Japan

Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices

Join us for our webinar with Sidley Austin and China Med Device for a comprehensive overview of China’s new regulatory policies.
先进医疗技术协会在全球积极倡导先进医疗技术发展,以促进人类生命健康与各国经济发展。
AdvaMed® members work around the globe, so we do, too.

The Chinese government announced a process to export particular devices without NMPA approval.

Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
WASHINGTON, D.C. – The Advanced Medical Association (AdvaMed®) requested the United States Trade Representative (USTR) provide additional tariff exclusions for medical devices, components and supplies coming from China needed in…
WASHINGTON – New clinical evidence produced in recent weeks has shown the benefits of non-invasive ventilators for use in less severe cases of COVID-19-related respiratory problems, which constitute the majority…
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…